TTYH3 chloride conductance in lysosomes and effects on fusion, autophagy and senescence
In this abstract, the protein TTYH3 is reported to mediate chloride efflux from lysosomes, promote lysosomal fusion and autophagy, and alleviate cellular senescence in cells; the work is preclinical and does not show effects on human aging. [1]
Automatic summary · not editorially reviewed
The key findings
TTYH3 is reported to mediate chloride efflux from the lysosomal lumen and to enhance TRPML1-mediated lysosomal calcium release. [1]
Overexpression of TTYH3 is reported to markedly enlarge lysosomes by promoting lysosomal fusion via the Ca/CaM and HSP90 pathways. [1]
The authors propose TTYH3 as a potential therapeutic target for interventions in aging and lysosome-related diseases. [1]
The source at a glance
- Study type / format
- Preclinical mechanistic study (abstract)
- Population / context
- Cells and lysosomes in laboratory experiments, as described in the abstract
- Summary based on
- Study abstract
- Original publication
- July 18, 2026
TTYH3 as lysosomal chloride regulator in cells
The abstract describes chloride as the most abundant anion in lysosomes and notes that how lysosomal chloride balance is controlled was largely unclear. The authors identify TTYH3 as a regulator of lysosomal chloride permeability: it mediates chloride efflux from the lysosomal lumen and enhances calcium release from lysosomes mediated by TRPML1. These are cell-level mechanistic findings, not measurements in people.
Supporting source [1]
Enlarged lysosomes, autophagy and senescence in cells
According to the abstract, overexpression of TTYH3 markedly enlarges lysosomes by promoting lysosomal fusion through the Ca/CaM and HSP90 pathways. TTYH3 also enhances autophagy by inhibiting AKT/mTOR signaling and alleviates cellular senescence via activation of the ERK pathway. The abstract further states that TTYH3 expression mitigates cellular phenotypes linked to lysosomal storage diseases caused by deficiencies in another lysosomal chloride channel, CLN7.
Supporting source [1]
Abstract-only scope and proposed therapeutic target
The authors conclude that TTYH3 mediates a lysosomal chloride conductance and regulates lysosomal physiology and autophagy, and suggest it may be a potential therapeutic target for interventions in aging and lysosome-related diseases. This is a proposal, not a validated treatment. Only the abstract was reviewed; the full text was not reviewed, and the abstract reports no human study, sample size, follow-up or clinical outcome.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. The abstract reports cell-level mechanistic work and no human study, sample size, follow-up or clinical outcome. The therapeutic target is proposed, not validated.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Huang J, Wang Y, Xu Y, Wei Y, Yin X, Li J, Zeng Y, Chen M, Li C, Wang L, Li X, Qu L, Cang C. · europepmc.org · July 18, 2026